Dendreon Corp fka DNDNQ

[poorgradstudent]

>I dont think the science mattered as much to the fda as p values<

I disagree. For those panel members who were worried that 9901 was a "small" trial and that something else could have accounted for the survival benefit, it would have strengthened DNDN's case to show that the protocol was actually targeting PAP rather than showing conclusively that it *wasn't* targeting the intended antigen.

If someone tells you that they're the reason the team won the baseball game, but you see this person holds the bat upside down, then you start to have doubts...